Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-05-049767
Filing Date
2005-03-15
Accepted
2005-03-14 19:28:39
Documents
10
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 VIROPHARMA INCORPORATED FORM 10-K d10k.htm 10-K 1085561
2 FORM OF EMPLOYMENT AGREEMENT dex101.htm EX-10.1 12593
3 FORM OF INDEMNIFICATION AGREEMENT dex102.htm EX-10.2 48132
4 VIROPHARMA SEVERANCE PLAN dex1037.htm EX-10.37 57672
5 SCHEDULE OF RATIO TO EARNINGS TO FIXED CHARGES dex121.htm EX-12.1 23634
6 LIST OF SUBSIDIARIES dex21.htm EX-21 1674
7 CONSENT OF KPMG LLP dex23.htm EX-23 2359
8 SECTION 302 CHIEF EXECUTIVE OFFICER CERTIFICATION dex311.htm EX-31.1 6321
9 SECTION 302 CHIEF FINANCIAL OFFICER CERTIFICATION dex312.htm EX-31.2 6154
10 SECTION 906 CERTIFCATION dex321.htm EX-32.1 4208
  Complete submission text file 0001193125-05-049767.txt   1250987
Mailing Address 397 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 397 EAGLEVIEW BLVD EXTON PA 19341 6104587300
VIROPHARMA INC (Filer) CIK: 0000946840 (see all company filings)

EIN.: 232789550 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21699 | Film No.: 05679779
SIC: 2834 Pharmaceutical Preparations